Evidence-Based Medicine Guidelines
Intermediate acting versus (ultra-)long acting insulin for type 1 diabetes mellitus
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Intermediate Acting Versus (ultra-)long Acting Insulin for Type 1 Diabetes Mellitus." Evidence-Based Medicine Guidelines, John Wiley & Sons, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/451948/all/Intermediate_acting_versus__ultra__long_acting_insulin_for_type_1_diabetes_mellitus.
Intermediate acting versus (ultra-)long acting insulin for type 1 diabetes mellitus. Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. https://evidence.unboundmedicine.com/evidence/view/EBMG/451948/all/Intermediate_acting_versus__ultra__long_acting_insulin_for_type_1_diabetes_mellitus. Accessed March 24, 2025.
Intermediate acting versus (ultra-)long acting insulin for type 1 diabetes mellitus. (2025). In Evidence-Based Medicine Guidelines. John Wiley & Sons. https://evidence.unboundmedicine.com/evidence/view/EBMG/451948/all/Intermediate_acting_versus__ultra__long_acting_insulin_for_type_1_diabetes_mellitus
Intermediate Acting Versus (ultra-)long Acting Insulin for Type 1 Diabetes Mellitus [Internet]. In: Evidence-Based Medicine Guidelines. John Wiley & Sons; 2025. [cited 2025 March 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/451948/all/Intermediate_acting_versus__ultra__long_acting_insulin_for_type_1_diabetes_mellitus.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Intermediate acting versus (ultra-)long acting insulin for type 1 diabetes mellitus
ID - 451948
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/451948/all/Intermediate_acting_versus__ultra__long_acting_insulin_for_type_1_diabetes_mellitus
PB - John Wiley & Sons
DB - Evidence Central
DP - Unbound Medicine
ER -
